2 Minute Medicine Rewind September 25, 2023 | 2 Minute Medicine
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study 1. Intravenous dihydroergotamine (DHE) was found in this retrospective study to be an effective therapeutic option for refractory chronic migraine. 2. DHE was additionally safe for individuals with elevated risk for cardiovascular events and other cardiovascular
Source: 2minutemedicine.com